Rezultati pretrage - Schlander, Michael

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence od Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

The NICE ADHD health technology assessment: A review and critique od Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" od Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Health technology assessment (HTA) and economic evaluation: efficiency or fairness first od Richardson, Jeff, Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Income loss after a cancer diagnosis in Germany: An analysis based on the socio‐economic panel survey od Hernandez, Diego, Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Correspondence (letter to the editor): Unanswered Questions od Schlander, Michael, Schwarz, Oliver, Trott, Götz-Erik

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Resource allocation in the Covid-19 health crisis: are Covid-19 preventive measures consistent with the Rule of Rescue? od März, Julian W., Holm, Søren, Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment od Schlander, Michael, Hernandez-Villafuerte, Karla, Cheng, Chih-Yuan, Mestre-Ferrandiz, Jorge, Baumann, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network od Heard, Jean-Michel, Vrinten, Charlotte, Schlander, Michael, Bellettato, Cinzia Maria, van Lingen, Corine, Scarpa, Maurizio

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Fast zwei Jahre Coronapandemie aus der Perspektive von Krebsbetroffenen od Gaisser, Andrea, Eckford, Rachel D., Arndt, Volker, Doege, Daniela, Kludt, Evelyn, Ubels, Jasper, Schlander, Michael, Weg-Remers, Susanne

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Fast zwei Jahre Coronapandemie aus der Perspektive von Krebsbetroffenen od Gaisser, Andrea, Eckford, Rachel D., Arndt, Volker, Doege, Daniela, Kludt, Evelyn, Ubels, Jasper, Schlander, Michael, Weg-Remers, Susanne

Preuzmi cijeli tekst Preuzmi cijeli tekst

Fast zwei Jahre Coronapandemie aus der Perspektive von Krebsbetroffenen od Gaisser, Andrea, Eckford, Rachel D., Arndt, Volker, Doege, Daniela, Kludt, Evelyn, Ubels, Jasper, Schlander, Michael, Weg-Remers, Susanne

Preuzmi cijeli tekst Preuzmi cijeli tekst

Determining Value in Health Technology Assessment: Stay the Course or Tack Away? od Caro, J. Jaime, Brazier, John E., Karnon, Jonathan, Kolominsky-Rabas, Peter, McGuire, Alistair J., Nord, Erik, Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Treatment for ADHD: Is More Complex Treatment Cost-Effective for More Complex Cases? od Foster, E Michael, Jensen, Peter S, Schlander, Michael, Pelham, William E, Hechtman, Lily, Arnold, L Eugene, Swanson, James M, Wigal, Timothy

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates od Espin, Jaime, Schlander, Michael, Godman, Brian, Anderson, Pippa, Mestre-Ferrandiz, Jorge, Borget, Isabelle, Hutchings, Adam, Flostrand, Steven, Parnaby, Adam, Jommi, Claudio

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

The COVID-19 Pandemic and Cancer Patients in Germany: Impact on Treatment, Follow-Up Care and Psychological Burden od Eckford, Rachel D., Gaisser, Andrea, Arndt, Volker, Baumann, Michael, Kludt, Evelyn, Mehlis, Katja, Ubels, Jasper, Winkler, Eva C., Weg-Remers, Susanne, Schlander, Michael

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement od Schlander, Michael, Garattini, Silvio, Kolominsky-Rabas, Peter, Nord, Erik, Persson, Ulf, Postma, Maarten, Richardson, Jeff, Simoens, Steven, de Solà-Morales, Oriol, Tolley, Keith, Toumi, Mondher

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Moving Towards Accountability for Reasonableness – A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Rege... od Wagner, Monika, Samaha, Dima, Casciano, Roman, Brougham, Matthew, Abrishami, Payam, Petrie, Charles, Avouac, Bernard, Mantovani, Lorenzo, Sarría-Santamera, Antonio, Kind, Paul, Schlander, Michael, Tringali, Michele

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study od Thong, Melissa S. Y., Doege, Daniela, Weißer, Linda, Koch-Gallenkamp, Lena, Bertram, Heike, Eberle, Andrea, Holleczek, Bernd, Nennecke, Alice, Waldmann, Annika, Zeissig, Sylke Ruth, Pritzkuleit, Ron, Schlander, Michael, Brenner, Hermann, Arndt, Volker

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL) od Annemans, Lieven, Aymé, Ségolène, Le Cam, Yann, Facey, Karen, Gunther, Penilla, Nicod, Elena, Reni, Michele, Roux, Jean-Louis, Schlander, Michael, Taylor, David, Tomino, Carlo, Torrent-Farnell, Josep, Upadhyaya, Sheela, Hutchings, Adam, Le Dez, Lugdivine

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst